Health and Fitness Health and Fitness
Tue, February 24, 2009
[ 12:21 PM ] - Market Wire
Schaeffer's Market Blog: Merck & Co. Slashes Its Sales Force
[ 12:00 PM ] - Market Wire
Alnylam Pharmaceuticals Reports Fourth Quarter and 2008 Financial Results
[ 11:55 AM ] - Market Wire
Capital Senior Living Corporation Announces Release Date for Fourth Quarter 2008 Financial Results
[ 08:30 AM ] - Market Wire
SCOR: SCOR implements the Paris Hub
[ 07:30 AM ] - Market Wire
MediSys Corporation: MediSys Corporation's Medica .. es Mainstream On NBC's "The Today Show"
[ 06:51 AM ] - Market Wire
Insulet Corp.: Insulet Announces Winners of OmniPod Video Contest
[ 06:30 AM ] - Market Wire
Trimedyne, Inc.: Trimedyne Reports Its Financial Results for the Quarter Ended December 31, 2008
[ 06:30 AM ] - Market Wire
Zila to Introduce ViziLite Plus in India
[ 06:00 AM ] - Market Wire
Midland Exploration Inc.: New Exploration Program on Midland James Bay Gold Project
[ 06:00 AM ] - Market Wire
Luminex Corporation Announces the Release of xPONENT® 3.1 Software
[ 06:00 AM ] - Market Wire
Exactech Receives Patent for Rotating Bearing Knee, Optetrak RBK System
[ 05:48 AM ] - Market Wire
Cerus Announces Marketing Authorization Granted to Largest Region of German Red Cross
[ 05:18 AM ] - Market Wire
Harvard Pilgrim Health Care Initiates Coverage for Microvolt T-Wave Alternans Testing
[ 05:00 AM ] - Market Wire
Medtronic to Voluntarily Disclose Payments To U.S. Physicians
[ 05:00 AM ] - Market Wire
ImmunoCellular Therapeutics Identifies Novel Pept .. Broaden Applicability of Cancer Stem Cell Vaccine
[ 05:00 AM ] - Market Wire
Marshall Edwards, Inc.: Yale Researchers Present .. iol Clinical Trial in Prostate Cancer Patients at
[ 05:00 AM ] - Market Wire
HemaCare Corporation: HemaCare Reports Record 4th Quarter and 2008 Revenues
[ 04:30 AM ] - Market Wire
Health Net Announces New Enterprise-Wide Quality Office
[ 04:30 AM ] - Market Wire
Free Electronic Prescribing Service Now Available to San Antonio Physicians
[ 04:30 AM ] - Market Wire
Allana Resources Inc.: Allana Resources Exhibits at PDAC, Booth 2529
[ 04:30 AM ] - Market Wire
FONAR Corporation: 2009 AIMBE Award for Discovery of MRI to Raymond Damadian, M.D., Founder/FONAR
[ 04:00 AM ] - Market Wire
Optimer Pharmaceuticals Announces Positive Result .. f Prulifloxacin for Infectious Diarrhea in Travel
[ 04:00 AM ] - Market Wire
St. Jude Medical Receives Australian TGA Regulato .. for the World?s Smallest and Longest-Lasting Rec
[ 04:00 AM ] - Market Wire
Assisted Living Concepts, Inc.: Assisted Living C .. Fourth Quarter and Full Year Results -- Solid Fou
[ 03:30 AM ] - Market Wire
I-Flow Corporation to Release Fourth-Quarter & 20 .. February 26, 2009; Webcast Set for 11:00 a.m. EST
[ 03:30 AM ] - Market Wire
Cypress Bioscience Inc.: Cypress Bioscience, Inc. .. ne Technology Platform From Cellatope Corporation
[ 03:00 AM ] - Market Wire
Salix Pharmaceuticals Announces 4Q2008 and FY2008 Financial Results Conference Call and Webcast
[ 03:00 AM ] - Market Wire
Samenvatting: Biogen Idec benoemt Michael Lytton .. executive vice president van Business Development
[ 03:00 AM ] - Market Wire
CPEX Pharmaceuticals Initiates Phase II Clinical Trial of Nasulin®
[ 02:37 AM ] - Market Wire
Resumen: Biogen Idec nombra a Michael Lytton vicepresidente ejecutivo de desarrollo empresarial

Resumen: Biogen Idec nombra a Michael Lytton vicepresidente ejecutivo de desarrollo empresarial


Published on 2009-02-24 03:49:27, Last Modified on 2009-02-24 03:49:59 - Market Wire
  Print publication without navigation


CAMBRIDGE, Massachussets--([ BUSINESS WIRE ])--Biogen Idec (NASDAQ: BIIB) ha nombrado vicepresidente ejecutivo del departamento de desarrollo empresarial y corporativo a Michael E. Lytton. En este nuevo cargo, Lytton será responsable de dirigir las actividades de desarrollo empresarial de la empresa.

"Michael aporta su gran experiencia de más de 25 años en el desarrollo empresarial, legal y de inversión en la industria biotecnológica", comentó Hans Peter Hasler, director de operaciones de Biogen Idec. "Su experiencia en fusiones y adquisiciones de empresas, así como su dominio para identificar y saber convertir proyectos científicos prometedores en grandes empresas, le convierten en el candidato ideal para seguir llevando a cabo nuestro récord de desarrollo empresarial altamente disciplinado y productivo".

El comunicado en el idioma original, es la versión oficial y autorizada del mismo. La traducción es solamente un medio de ayuda y deberá ser comparada con el texto en idioma original, que es la única versión del texto que tendrá validez legal.

Contributing Sources